Annual Working Capital
$345.77 M
+$14.51 M+4.38%
December 31, 2023
Summary
- As of February 7, 2025, DAWN annual working capital is $345.77 million, with the most recent change of +$14.51 million (+4.38%) on December 31, 2023.
- During the last 3 years, DAWN annual working capital has risen by +$302.69 million (+702.71%).
- DAWN annual working capital is now at all-time high.
Performance
DAWN Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$541.25 M
+$251.80 M+86.99%
September 30, 2024
Summary
- As of February 7, 2025, DAWN quarterly working capital is $541.25 million, with the most recent change of +$251.80 million (+86.99%) on September 30, 2024.
- Over the past year, DAWN quarterly working capital has increased by +$195.49 million (+56.54%).
- DAWN quarterly working capital is now at all-time high.
Performance
DAWN Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
DAWN Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.4% | +56.5% |
| 3 y3 years | +702.7% | +49.4% |
| 5 y5 years | +1265.7% | +49.4% |
DAWN Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +23.2% | at high | +108.8% |
| 5 y | 5-year | at high | +1265.7% | at high | +1156.5% |
| alltime | all time | at high | +1265.7% | at high | +1156.5% |
Day One Biopharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $541.25 M(+87.0%) |
| Jun 2024 | - | $289.45 M(-2.3%) |
| Mar 2024 | - | $296.19 M(-14.3%) |
| Dec 2023 | $345.77 M(+4.4%) | $345.77 M(-11.1%) |
| Sep 2023 | - | $388.82 M(-8.6%) |
| Jun 2023 | - | $425.27 M(+42.0%) |
| Mar 2023 | - | $299.54 M(-9.6%) |
| Dec 2022 | $331.26 M | $331.26 M(-8.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $362.24 M(-7.0%) |
| Jun 2022 | - | $389.70 M(+50.4%) |
| Mar 2022 | - | $259.19 M(-7.7%) |
| Dec 2021 | $280.71 M(+551.7%) | $280.71 M(-5.6%) |
| Sep 2021 | - | $297.26 M(-4.5%) |
| Jun 2021 | - | $311.36 M(+100.0%) |
| Mar 2021 | - | $155.69 M(+261.4%) |
| Dec 2020 | $43.08 M(+70.1%) | $43.08 M |
| Dec 2019 | $25.32 M | - |
FAQ
- What is Day One Biopharmaceuticals annual working capital?
- What is the all time high annual working capital for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals annual working capital year-on-year change?
- What is Day One Biopharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals quarterly working capital year-on-year change?
What is Day One Biopharmaceuticals annual working capital?
The current annual working capital of DAWN is $345.77 M
What is the all time high annual working capital for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high annual working capital is $345.77 M
What is Day One Biopharmaceuticals annual working capital year-on-year change?
Over the past year, DAWN annual working capital has changed by +$14.51 M (+4.38%)
What is Day One Biopharmaceuticals quarterly working capital?
The current quarterly working capital of DAWN is $541.25 M
What is the all time high quarterly working capital for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high quarterly working capital is $541.25 M
What is Day One Biopharmaceuticals quarterly working capital year-on-year change?
Over the past year, DAWN quarterly working capital has changed by +$195.49 M (+56.54%)